AAM
WST icon

Arabesque Asset Management’s West Pharmaceutical WST Stock Holding History

Arabesque Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,025
Closed -$481K – 203
2021
Q4 		$481K Buy
1,025
+199
+24% +$85.7K 0.14% 138
2021
Q3 		$351K Sell
826
-629
-43% -$265K 0.12% 140
2021
Q2 		$522K Buy
+1,455
New +$481K 0.22% 111
2020
Q4 		– Sell
-11,236
Closed -$3.09M – 105
2020
Q3 		$3.09M Sell
11,236
-4,227
-27% -$1.12M 2.78% 3
2020
Q2 		$3.51M Buy
+15,463
New +$3.04M 2.38% 6

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Arabesque Asset Management's WST Position: Q1 2022 in Review

Arabesque Asset Management sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 1,025 shares — an estimated $481K sold.

Arabesque Asset Management first reported a position in WST in Q2 2020 and held it in 5 quarters. The position peaked at $3.51M in Q2 2020. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Arabesque Asset Management reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Arabesque Asset Management sold 1,025 West Pharmaceutical shares in Q1 2022, an estimated $481K.
  • Arabesque Asset Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 5 quarters.
  • Arabesque Asset Management's West Pharmaceutical position peaked at $3.51M in Q2 2020.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Arabesque Asset Management's 13F filing for Q1 2022, filed 16 May 2022.